Department of Anesthesiology and Intensive Medicine, General Hospital Dr Josip Benčević, Slavonski Brod, Croatia.
Disaster Med Public Health Prep. 2022 May 2;17:e151. doi: 10.1017/dmp.2022.102.
Despite widespread use of noninvasive ventilation (NIV) in some coronavirus disease 2019 (COVID-19) hypoxemic patients, its clinical application is still subject of debate.
This is a retrospective, observational study with data collected from 91 consecutive patients treated in COVID intensive care unit (ICU) in our institution between October 2020 and February 2021. Outcomes were represented as ventilation hours, ICU and hospital length of stay, and ICU and hospital mortality.
Patients' mean age was 66 ± 11 y and severe COVID-19 pneumonia with mean paO/FiO 137 ± 57 was observed in 90% of the patients. High positive end-expiratory pressure (PEEP) NIV by means of total face mask was initially applied in 58 (64%) patients, high flow oxygen therapy (HFOT) in 25 (27%) patients, whilst invasive mechanical ventilation (IMV) started at the moment of admission in 8 (9%) patients. NIV and high flow oxygen therapy (HFOT) have been kept on throughout ICU stay in 50 (55%) patients, while 41 (45%) patients were put on IMV. Overall ICU mortality was 41%, while ICU mortality of patients on NIV was 14%.
High PEEP NIV was convenient and safe as initial respiratory support and in some COVID-19 ARDS patients remained an optimal respiratory support throughout their disease.
尽管在一些 COVID-19 低氧血症患者中广泛应用无创通气(NIV),但其临床应用仍存在争议。
这是一项回顾性观察性研究,数据来自 2020 年 10 月至 2021 年 2 月期间我院 COVID-19 重症监护病房(ICU)连续收治的 91 例患者。结果表示为通气时间、ICU 和住院时间以及 ICU 和住院死亡率。
患者平均年龄为 66 ± 11 岁,90%的患者患有严重 COVID-19 肺炎,平均 paO/FiO 为 137 ± 57。最初有 58 例(64%)患者采用全面罩高正压通气(NIV),25 例(27%)患者采用高流量氧疗(HFOT),8 例(9%)患者入院时即开始有创机械通气(IMV)。50 例(55%)患者在 ICU 期间持续接受 NIV 和 HFOT,41 例(45%)患者接受 IMV。总的 ICU 死亡率为 41%,而接受 NIV 的患者的 ICU 死亡率为 14%。
高 PEEP NIV 作为初始呼吸支持方便且安全,在一些 COVID-19 急性呼吸窘迫综合征患者中,在整个疾病过程中仍然是一种最佳的呼吸支持。